Answers are grounded in this paper and cite their sources.
These observations demonstrate that when the guardrails of AI tools are insufficient, the ability to rapidly generate diverse and large amounts of convincing disinformation is profound. Beyond providing 2 example scenarios, these findings demonstrate an urgent need for robust AI vigilance. The AI tools are rapidly progressing; alongside these advancements, emergent risks are becoming increasingly apparent. Key pillars of pharmacovigilance-including transparency, surveillance, and regulation-may serve as valuable examples for managing these risks and safeguarding public health.
No takes yet. Share an insight, caveat, or question.
Menz et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: